Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

549.16
+16.383.07%
Post-market: 549.160.00000.00%19:30 EDT
Volume:577.86K
Turnover:315.99M
Market Cap:23.55B
PE:19.65
High:551.15
Open:528.92
Low:528.92
Close:532.78
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.52
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.68
PE(LYR):19.71

Loading ...

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), United Therapeutics (UTHR) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS)

TIPRANKS
·
Yesterday

United Therapeutics Chairperson, CEO Martine Rothblatt Disposes of USD 4.88 Million in Common Shares

Reuters
·
Yesterday

RBC Raises Price Target on United Therapeutics to $708 From $677, Keeps Outperform Rating

MT Newswires Live
·
Oct 08

United Therapeutics Price Target Raised to $566.00/Share from $515.00 by Morgan Stanley

Dow Jones
·
Oct 07

United Therapeutics Chairperson, CEO Martine Rothblatt Disposes of Shares Worth $4.91 Million

Reuters
·
Oct 07

United Therapeutics Corporation : JP Morgan Raises Target Price to $710 from $687

THOMSON REUTERS
·
Oct 06

United Therapeutics Chairperson, CEO Martine Rothblatt Reports USD 4.99 Million Common Stock Disposal

Reuters
·
Oct 03

Movement Alert|United Therapeutics Falls 5.19% in Regular Trading, Trading at $542.915

Market Focus
·
Oct 03

United Therapeutics Corp Stock (UTHR) Moved Up by 7.26% on Oct 1: What Investors Need To Know

TradingKey
·
Oct 02

Movement Alert|United Therapeutics Rises 6.63% in Regular Trading, Federal Court Patent Victory Over Liquidia Fuels Gains

Market Focus
·
Oct 02

HLS Therapeutics Appoints Linda Maxwell, Mark DeLong as Independent Directors

Reuters
·
Oct 01

BTIG Upgrades United Therapeutics to Buy From Neutral, Price Target is $728

MT Newswires Live
·
Oct 01

United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia

THOMSON REUTERS
·
Oct 01

United Therapeutics CEO Martine A. Rothblatt Disposes of Shares Worth $4,287,172.85

Reuters
·
Oct 01

Top Midday Decliners

MT Newswires Live
·
Oct 01

RBC Capital Remains a Buy on United Therapeutics (UTHR)

TIPRANKS
·
Oct 01

Liquidia Found to Infringe United Therapeutics Patent in Court Ruling

MT Newswires Live
·
Oct 01

Patent ruling ‘a meaningful positive’ for United Therapeutics, says RBC Capital

TIPRANKS
·
Oct 01

United Therapeutics on Pace for Largest Percent Increase Since September 2025

Dow Jones
·
Oct 01